Navigation Links
Reportlinker Adds Prostate Cancer - Spain Drug Forecasts and Treatment Analysis to 2020
Date:12/8/2010

Estrace tablet 78

4.3.13 Tace 79

4.3.14 Nilandrone 80

4.3.15 Premarin 81

4.3.16 Sales Forecast for Trelstar, Decapeptyl, Gonapeptyl, Flutamide, Estradiol 82

5 Pipeline Assessment 83

5.1 Overview 83

5.2 Pipeline Analysis by Phase of Development 84

5.3 Pipeline by Mechanism of Action 85

5.4 Strategic Pipeline Assessment 86

5.4.1 Technology Trends Analytical Framework 86

5.5 Trends in Prostate Cancer Pipeline 87

5.5.1 More Clarity on the Origin of Prostate Cancer Will Help in Identifying Novel Targets for Prostate Cancer Drugs 87

5.5.2 Molecules with Novel Mechanism of Action Strengthening Prostate Cancer Pipeline 87

5.5.3 Failure of Key Molecules to Achieve Positive Results in Phase III Development 88

5.6 Partners in Research and Development 88

5.6.1 Licensing Agreements by Phase of Development 89

5.6.2 Licensing Agreements by Geography 92

5.6.3 Licensing Agreements: Technology Licensing Agreements in Prostate Cancer 92

5.7 Most Promising Drugs' Profiles 93

5.7.1 Provenge (sipuleucel-T) 95

5.7.2 Jevtana (cabazitaxel) 97

5.7.3 Aflibercept (VEGF Trap) 99

5.7.4 Ipilimumab 101

5.7.5 Abiraterone Acetate (CB7630) 104

5.7.6 Zibotentan (ZD4054) 107

5.7.7 Sprycel (dasatinib) 109

5.7.8 MDV3100 111

5.8 Prostate Cancer Pipeline – Pre-clinical Phase 114

5.9 Prostate Cancer Pipeline – Phase I 116

5.10 Prostate Cancer Pipeline – Phase II 119

5.11 Prostate Cancer Pipeline – Phase III 128

5.12 Key Takeaway 130

6 Unmet Need and Target Product Profile 131

6.1 Unmet Need 133

6.1.1 Hormone-independent Metastatic Prostate Cancer Therapy 133

6.1.2 Hormone-dependent Metastatic Prostate Cancer Therapy 134

6.2 Opportunity for Target Product 135

6.3 Target Product Profile 138

6.3.1 Ideal Characteristic
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Calif., Feb. 27, 2015 Isis Pharmaceuticals, Inc. ... outperformed both its pro forma net operating loss (NOL) ... a strong financial position.  Isis, significantly improved financial results ... $230 million in payments the Company received from its ... 2014 was a nearly 60% improvement over its 2013 ...
(Date:2/27/2015)... N.J. , Feb. 27, 2015 An ... has helped cut the rate of infection with a ... 40 percent. Clostridium difficile, or C.diff, is ... to life-threatening inflammation of the colon. A recent article ... of Clostridium difficile Infection in the United ...
(Date:2/27/2015)... -- Report Details   Translational ... progress, and predicted revenues ,Where is the market for ... prospects for this market and related technologies? Visiongain,s brand ... to 2025, discussing data, opportunities and prospects. ... medicine : cell-based therapies that aim to restore function ...
Breaking Medicine Technology:Isis Reports Financial Results and Highlights for 2014 2Isis Reports Financial Results and Highlights for 2014 3Isis Reports Financial Results and Highlights for 2014 4Isis Reports Financial Results and Highlights for 2014 5Isis Reports Financial Results and Highlights for 2014 6Isis Reports Financial Results and Highlights for 2014 7Isis Reports Financial Results and Highlights for 2014 8Isis Reports Financial Results and Highlights for 2014 9Isis Reports Financial Results and Highlights for 2014 10Isis Reports Financial Results and Highlights for 2014 11Isis Reports Financial Results and Highlights for 2014 12Isis Reports Financial Results and Highlights for 2014 13Isis Reports Financial Results and Highlights for 2014 14Isis Reports Financial Results and Highlights for 2014 15Isis Reports Financial Results and Highlights for 2014 16Isis Reports Financial Results and Highlights for 2014 17Curb Overuse Of Antibiotics To Reduce Drug-Resistant Superbug 2Curb Overuse Of Antibiotics To Reduce Drug-Resistant Superbug 3Translational Regenerative Medicine: Market Prospects 2015-2025 2Translational Regenerative Medicine: Market Prospects 2015-2025 3Translational Regenerative Medicine: Market Prospects 2015-2025 4Translational Regenerative Medicine: Market Prospects 2015-2025 5Translational Regenerative Medicine: Market Prospects 2015-2025 6Translational Regenerative Medicine: Market Prospects 2015-2025 7Translational Regenerative Medicine: Market Prospects 2015-2025 8
... , ABBOTT PARK, Ill., Feb. 11 Abbott ... and Drug Administration (FDA) has granted approval of a new tablet ... Norvir tablets can be stored at room temperature and ... Norvir tablets and the Norvir soft-gelatin capsules both contain 100 mg ...
... , , HONG KONG , Feb. ... been enrolled in a randomized clinical trial of the Genous Bio-engineered ... study, the trial will enroll 180 patients split evenly between the ... primary study objective is to demonstrate the safety and effectiveness of ...
Cached Medicine Technology:Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets 2Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets 3Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets 4Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets 5Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets 6Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets 7Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets 8Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets 9Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets 10Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets 11Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets 12Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets 13OrbusNeich Announces First Patient Enrolled in Randomized Clinical Trial of Genous(TM) Bio-engineered R stent(TM) in China 2OrbusNeich Announces First Patient Enrolled in Randomized Clinical Trial of Genous(TM) Bio-engineered R stent(TM) in China 3
(Date:2/27/2015)... 27, 2015 On March 2-4, ... the National Cancer Institute (NCI) will co-host the ... National Institutes of Health (NIH), in Bethesda, Maryland. ... dedicated to medical professionals and scientists who specialize ... the general public, including patients, their families, and ...
(Date:2/27/2015)... 27, 2015 In honor of American Heart Month ... (CPC) South office, is offering tips on how to improve heart ... but that doesn't mean people have to accept it as their ... factors — such as family history, sex or age — there ... Dr. Scott has six helpful tips to improve heart health and ...
(Date:2/27/2015)... Freeport, ME (PRWEB) February 27, 2015 Royal ... Freeport, ME, reports a new study that found adults who ... to develop type 2 diabetes compared to those who got ... elevated blood sugar levels. , The report is part of ... Being® ,” which Royal River Natural Foods publishes free each ...
(Date:2/27/2015)... 27, 2015 Adding to its ... pharmaceuticals, Benedict Advertising & Marketing has added Sedation ... The company’s patented NITROUSEAL® N20 closed mask and ... of sedation. , Sedation Systems, http://www.sedationsystems.com ... a new level, though it focuses primarily on ...
(Date:2/27/2015)... 27, 2015 FACE Skincare~Medical~Wellness, a ... announced a unique combination to take fifteen years ... Décolletage is a new treatment introduced that is ... specifically indicated to improve lines and wrinkles on ... person who suffers from the stubborn vertical lines ...
Breaking Medicine News(10 mins):Health News:Conference on Mesothelioma Co-Hosted with National Cancer Institute 2Health News:Conference on Mesothelioma Co-Hosted with National Cancer Institute 3Health News:Center for Primary Care Celebrates American Heart Month 2Health News:Center for Primary Care Celebrates American Heart Month 3Health News:Center for Primary Care Celebrates American Heart Month 4Health News:New Study Finds Magnesium May Slow Progress of Diabetes, Retailer Reports 2Health News:Benedict Advertising & Marketing Signs Sedation Systems 2Health News:Face Skincare Announces New Combination Therapy 2
... older brothers and sisters can be tough work, as any youngest ... at the University of North Carolina at Chapel Hill shows that ... sympathies for the first born or rather, first laid ... issue of PLoS ONE, runs somewhat counter to common wisdom, which ...
... demands solutions from presidential candidates, Congress, ... Independent Business (NFIB), the nation,s leading small ... Start Here, an,aggressive healthcare campaign that will ... reform for small business. Kicking off the,campaign, ...
... its Weight Watchers program and obesity training, state,s,largest Medicaid ... Association to provide medical professionals the opportunity ... certified in conducting Breathe Well, Live Well program, ... rank among the highest in the country in asthma ...
... Eating a Bowl May Increase Attentiveness by Nearly 20 Percent, ... going,to great lengths to help their kids do their best ... learning software and pack their,schedules with enrichment activities. While all ... one of the simplest ways to help,ensure their kids do ...
... 12 BioMarin,Pharmaceutical Inc. (Nasdaq and SWX: BMRN) announced ... present a,company update at the Lehman Brothers Global Healthcare ... p.m. ET., Interested parties may access a live ... the BioMarin website, http://www.BMRN.com . A,replay of the ...
... VIEW, Calif., March 12 Omnicell,Inc. (Nasdaq: OMCL ... facilities, announced today that it has completed its $40.0,million ... total of,2,133,898 shares were repurchased at an average price ... OMCL ) is a leading provider of systems ...
Cached Medicine News:Health News:Early bird doesn't always get worm, UNC researcher finds 2Health News:National Federation of Independent Business Launches Aggressive Campaign to Drive Healthcare Reform: Solutions Start Here 2Health News:National Federation of Independent Business Launches Aggressive Campaign to Drive Healthcare Reform: Solutions Start Here 3Health News:National Federation of Independent Business Launches Aggressive Campaign to Drive Healthcare Reform: Solutions Start Here 4Health News:UniCare of West Virginia Providing Assistance for Asthma Education Training 2Health News:UniCare of West Virginia Providing Assistance for Asthma Education Training 3Health News:Help Your Kids Earn an 'A' for Attentiveness with a Bowl of Frosted Mini- Wheats(R) Cereal for Breakfast 2Health News:Help Your Kids Earn an 'A' for Attentiveness with a Bowl of Frosted Mini- Wheats(R) Cereal for Breakfast 3Health News:Help Your Kids Earn an 'A' for Attentiveness with a Bowl of Frosted Mini- Wheats(R) Cereal for Breakfast 4Health News:BioMarin to Present at the Lehman Brothers Global Healthcare Conference 2Health News:Omnicell Announces Completion of Its Common Stock Repurchase Plan 2
... The CMGS-1 Color Mini-Ganzfeld Stimulator is ... can be integrated with your existing LKC ... with other visual electrodiagnostic test systems. ... is the smallest commercial Ganzfeld to meet ...
... the most advanced visual electrodiagnostic system ... of retinal and optic nerve function. ... drives this powerful computer-controlled instrument. With ... pattern stimulation, rapid Ganzfeld flash rate ...
... designed to facilitate an arthrodesis, either by ... interbody cages allowing radicular compression by restoring ... and of the foramina, which in turn ... for major lumbar instabilities.,CC cages are made ...
... SHELLGEL is a sterile nonpyrogenic, transparent ... SHELLGEL contains 12 mg/mL of high molecular ... hyaluronate dissolved in physiological saline. In the ... is 105,000 cps (105 Pa s) at ...
Medicine Products: